Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience

被引：0
|
作者：
Alicia Okines
Tazia Irfan
Bernice Asare
Kabir Mohammed
Peter Osin
Ashutosh Nerurkar
Ian E. Smith
Marina Parton
Alistair Ring
Stephen Johnston
Nicholas C. Turner
机构：
[1] The Royal Marsden NHS Foundation Trust,
[2] The Royal Marsden NHS Foundation Trust,undefined
来源：
Breast Cancer Research and Treatment | 2022年 / 192卷
关键词：
HER2; Lobular; Triple negative;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：563 / 571
页数：8
相关论文
共 50 条
  • [1] Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience
    Okines, Alicia
    Irfan, Tazia
    Asare, Bernice
    Mohammed, Kabir
    Osin, Peter
    Nerurkar, Ashutosh
    Smith, Ian E.
    Parton, Marina
    Ring, Alistair
    Johnston, Stephen
    Turner, Nicholas C.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (03) : 563 - 571
  • [2] Clinical Outcomes in HER2-positive Lobular Breast Cancer: a Single-institution Experience
    Irfan, T.
    Asare, B.
    Mohammed, K.
    Osin, P.
    Nerurkar, A.
    Smith, I.
    [J]. CLINICAL ONCOLOGY, 2019, 31 (07) : E109 - E110
  • [3] Clinical Outcomes in Triple-negative Lobular Breast Cancer: a Single-institution Experience
    Irfan, T.
    Turkes, F.
    Asare, B.
    Mohammed, K.
    Osin, P.
    Nerurkar, A.
    Smith, I.
    Parton, M.
    Johnston, S.
    Turner, N.
    Okines, A.
    [J]. CLINICAL ONCOLOGY, 2019, 31 (07) : E110 - E110
  • [4] Survival Analysis of Triple Negative and Her2 Positive Breast Cancer Patients: Single Center Report
    Varol, Umut
    Cakar, Burcu
    Yildiz, Ibrahim
    Dalgic, Ceyda Tunakan
    Ozisik, Hatice
    Ozisik, Melih
    Karaca, Burcak
    Karabulut, Bulent
    Uslu, Ruhan
    [J]. JOURNAL OF BREAST HEALTH, 2014, 10 (01): : 42 - 46
  • [5] Neoadjuvant therapy in patients with triple negative and HER2 positive early breast cancer
    Harbeck, N.
    [J]. BREAST, 2017, 32 : S18 - S18
  • [6] Tolerability of pertuzumab in older adults with HER2 positive breast cancer: A single institution experience
    Williams, Nicole
    Warmbier, Austin
    Doto, Dureti
    Palettas, Marilly
    Stephens, Julie
    Quiroga, Dionisia
    Johnson, Kai
    Pariser, Ashley
    Cherian, Mathew
    Sardesai, Sagar
    Stover, Daniel
    Gatti-Mays, Margaret
    Wesolowski, Robert
    Ramaswamy, Bhuvana
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [7] Efficacy and safety of pertuzumab for HER2 positive metastatic breast cancer: a single institution experience
    Hara, Fumikata
    Aogi, Kenjiro
    Takashima, Seiki
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 141 - 141
  • [8] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Irfan Cicin
    Hakan Karagol
    Ufuk Usta
    Atakan Sezer
    Sernaz Uzunoglu
    Rusen Alas-Cosar
    Tarkan Yetisyigit
    Kazim Uygun
    [J]. Medical Oncology, 2009, 26 : 335 - 343
  • [9] Triple negative breast cancer compared to hormone receptor negative/HER2 positive breast cancer
    Cicin, Irfan
    Karagol, Hakan
    Usta, Ufuk
    Sezer, Atakan
    Uzunoglu, Sernaz
    Alas-Cosar, Rusen
    Yetisyigit, Tarkan
    Uygun, Kazim
    [J]. MEDICAL ONCOLOGY, 2009, 26 (03) : 335 - 343
  • [10] A SINGLE INSTITUTION EXPERIENCE WITH TRIPLE NEGATIVE BREAST CANCER
    Rezazadeh, A.
    Kloecker, G.
    Kruse, B. B.
    Jain, D.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 49 - 49
12345